Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directions
Open Access
- 1 July 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 24 (3) , 251-262
- https://doi.org/10.1111/j.1574-6976.2000.tb00541.x
Abstract
Antibacterial chemotherapy is particularly striking in the family of penicillins and cephalosporins. Over 40 structurally different β-lactam moleculeKeywords
This publication has 81 references indexed in Scilit:
- Antibiotic Resistance: Proceedings of a Symposium Held on 12 July 1996 at the University of SouthamptonJournal of Medical Microbiology, 1997
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coliAntimicrobial Agents and Chemotherapy, 1995
- A functional classification scheme for beta-lactamases and its correlation with molecular structureAntimicrobial Agents and Chemotherapy, 1995
- -Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical ImpactClinical Infectious Diseases, 1992
- Activity of clavulanate combinations against TEM-1 β-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989Journal of Antimicrobial Chemotherapy, 1991
- Hyperproduction of TEM-1 beta-lactamase in clinical isolates ofEscherichia coliserotype O15FEMS Microbiology Letters, 1990
- Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion testsAntimicrobial Agents and Chemotherapy, 1988
- AMOXYCILLIN/CLAVULANATE RESISTANT ESCHERICHIA COLIThe Lancet, 1988
- RESISTANCE TO BETA-LACTAM/CLAVULANATEThe Lancet, 1987